Contact Us
  • This field is for validation purposes and should be left unchanged.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

A. Development or evaluation of pharmacological agents (i.e., drugs, therapeutics), gene therapies, cell-based or other biological technologies for intervention in or prevention of Diabetes and Digestive and Kidney Diseases.
B. Development or evaluation of biomedical devices, tools, or instrumentation for intervention in or prevention of Diabetes and Digestive and Kidney Diseases.
C. Development of biomarkers, assays, diagnostic technologies or associated reagents for assessing state or function in normal, developing, or diseased cells or tissues affected by Diabetes and Digestive and Kidney Diseases.
D. Development or evaluation of imaging, screening, or evaluation technologies for assessing state or function in normal, developing, or diseased cells or tissues affected by Diabetes and Digestive and Kidney Diseases.
E. Development or evaluation of animal or cell models for studying Diabetes and Digestive and Kidney Diseases.
F. Development or evaluation of novel materials or material treatments (e.g., sterilization, coating, etc.) for use in devices or other tools or methods used to prevent, diagnose, or treat Diabetes and Digestive and Kidney Diseases.
G. Development of cell- or data-banks for the biomedical research community.
H. Development or evaluation of technologies, including software applications, for improving patient adherence in Diabetes and Digestive and Kidney Diseases.
I. Development or evaluation of technologies for improving clinical research in Diabetes and Digestive and Kidney Diseases, including technologies for improving data collection and reporting of patient outcomes.
J. Development or evaluation of ?omics, informatics, or internet-based technologies for biomedical research or clinical applications in diagnosing or managing Diabetes and Digestive and Kidney Diseases.
K. Development or evaluation of technologies to prevent or avert cell or tissue injury during other disease states or surgical procedures.

Contact Us
  • This field is for validation purposes and should be left unchanged.